34959172|t|ARN25068, a versatile starting point towards triple GSK-3beta/FYN/DYRK1A inhibitors to tackle tau-related neurological disorders.
34959172|a|The human kinome plays a crucial role in several pathways. Its dysregulation has been linked to diverse central nervous system (CNS)-related disorders with a drastic impact on the aging population. Among them, tauopathies, such as Alzheimer's Disease (AD) and Frontotemporal Lobar degeneration (FTLD-tau), are neurodegenerative disorders pathologically defined by the presence of hyperphosphorylated tau-positive intracellular inclusions known as neurofibrillary tangles (NFTs). Compelling evidence has reported the great potential of the simultaneous modulation of multiple protein kinases (PKs) involved in abnormal tau phosphorylation through a concerted pharmacological approach to achieve a superior therapeutic effect relative to classic "one target, one drug" approaches. Here, we report on the identification and characterization of ARN25068 (4), a low nanomolar and well-balanced dual GSK-3beta and FYN inhibitor, which also shows inhibitory activity against DYRK1A, an emerging target in AD and tauopathies. Computational and X-Ray studies highlight compound 4's typical H-bonding pattern of ATP-competitive inhibitors at the binding sites of all three PKs. In a tau phosphorylation assay on Tau0N4R-TM-tGFP U2OS cell line, 4 reduces the extent of tau phosphorylation, promoting tau-stabilized microtubule bundles. In conclusion, this compound emerges as a promising prototype for further SAR explorations to develop potent and well-balanced triple GSK-3beta/FYN/DYRK1A inhibitors to tackle tau hyperphosphorylation.
34959172	0	8	ARN25068	Chemical	-
34959172	52	61	GSK-3beta	Gene	2932
34959172	62	65	FYN	Gene	2534
34959172	66	72	DYRK1A	Gene	1859
34959172	94	97	tau	Gene	4137
34959172	106	128	neurological disorders	Disease	MESH:D009461
34959172	134	139	human	Species	9606
34959172	234	280	central nervous system (CNS)-related disorders	Disease	MESH:D002493
34959172	340	351	tauopathies	Disease	MESH:D024801
34959172	361	380	Alzheimer's Disease	Disease	MESH:D000544
34959172	382	384	AD	Disease	MESH:D000544
34959172	390	423	Frontotemporal Lobar degeneration	Disease	MESH:D057174
34959172	425	433	FTLD-tau	Disease	MESH:D057174
34959172	440	467	neurodegenerative disorders	Disease	MESH:D019636
34959172	530	533	tau	Gene	4137
34959172	577	600	neurofibrillary tangles	Disease	MESH:D055956
34959172	602	606	NFTs	Disease	MESH:D055956
34959172	748	751	tau	Gene	4137
34959172	971	983	ARN25068 (4)	Chemical	-
34959172	1024	1033	GSK-3beta	Gene	2932
34959172	1038	1041	FYN	Gene	2534
34959172	1098	1104	DYRK1A	Gene	1859
34959172	1128	1130	AD	Disease	MESH:D000544
34959172	1135	1146	tauopathies	Disease	MESH:D024801
34959172	1232	1235	ATP	Chemical	MESH:D000255
34959172	1303	1306	tau	Gene	4137
34959172	1348	1352	U2OS	CellLine	CVCL:0042
34959172	1388	1391	tau	Gene	4137
34959172	1419	1422	tau	Gene	4137
34959172	1589	1598	GSK-3beta	Gene	2932
34959172	1599	1602	FYN	Gene	2534
34959172	1603	1609	DYRK1A	Gene	1859
34959172	Association	2932	4137
34959172	Association	MESH:D055956	4137
34959172	Association	MESH:D024801	1859
34959172	Association	2534	4137
34959172	Positive_Correlation	MESH:D057174	4137
34959172	Association	MESH:D009461	2932
34959172	Association	MESH:D009461	1859
34959172	Association	MESH:D009461	4137
34959172	Association	MESH:D000544	1859
34959172	Association	MESH:D009461	2534

